What is Ledger Run?
Ledger Run, Inc. operates at the intersection of financial technology and clinical research, providing the ClinRun platform to streamline complex trial operations. By automating site contracts, budgeting, and payment workflows, the company addresses critical bottlenecks that often delay pharmaceutical development. Its solution is specifically engineered for sponsors and Contract Research Organizations (CROs) seeking to enhance transparency and operational control. By integrating seamlessly with existing enterprise systems, Ledger Run enables life sciences teams to maintain established workflows while significantly reducing the administrative burden associated with trial startup and site management. This focus on efficiency and site satisfaction positions the company as a vital partner in the modern drug development ecosystem.
How much funding has Ledger Run raised?
Ledger Run has raised a total of $186K across 1 funding round:
Debt
$186K
Debt (2021): $186K with participation from PPP
Key Investors in Ledger Run
PPP
Public-Private Partnership
What's next for Ledger Run?
With this late-stage funding, Ledger Run is poised to accelerate its market penetration and enhance its product suite to meet the evolving demands of global clinical trials. The strategic allocation of these resources will likely focus on scaling the ClinRun platform's capabilities, potentially through deeper integrations with decentralized trial technologies and advanced analytics. As the life sciences industry continues to prioritize speed-to-market and financial rigor, Ledger Run's ability to provide automated, transparent, and compliant financial operations will be a key driver of its future growth. The company is expected to leverage this capital to strengthen its competitive advantage, ensuring that sponsors and CROs can navigate the complexities of trial management with greater agility and precision.
See full Ledger Run company page
